English Français

Medexus Pharmaceuticals, Inc. Medexus Pharmaceuticals, Inc.

  • English
  • About
    • Overview
    • Growth Strategy
    • Management Team
    • Board of Directors
  • Our Portfolio
    • Overview
    • Canadian Product Portfolio
    • US Product Portfolio
  • News
    • Press Releases
    • Events
  • Investors
    • Overview
    • News & Events
    • Company Info
    • Presentation
    • Financial Results
    • Stock Data
    • Governance
    • SEDAR
  • Contact
  • Careers
  • English
  • Français

Press Releases

News

News

  • Press Releases
  • Events
Mar 22, 2023 7:20am EDT

Medexus Announces New License Deal for Topical Terbinafine

Mar 08, 2023 5:00pm EST

Medexus Announces US$58.5 million in New Credit Facilities

Mar 06, 2023 8:00am EST

Medexus to Participate in 35th Annual Roth Conference

Feb 08, 2023 5:00pm EST

Medexus Announces Another Record Quarter with Fiscal Q3 2023 Revenue of US$28.7 Million, a 35% Increase Over Fiscal Q3 2022

Feb 06, 2023 5:00pm EST

Medexus Welcomes Two New Board Members

Feb 01, 2023 5:00pm EST

Medexus Secures Public Reimbursement for Cuvposa® in Quebec

Jan 31, 2023 5:00pm EST

Medexus Schedules Third Fiscal Quarter 2023 Conference Call

Jan 12, 2023 7:30am EST

Medexus Expects Record Revenue for Fiscal Q3 2023 and Provides Business Update

Nov 08, 2022 5:30pm EST

Medexus Announces Strongest Quarter in Company History with Fiscal Q2 2023 Revenue of US$27.7 Million, a 55% Increase Over Fiscal Q2 2022

Nov 02, 2022 8:00am EDT

Medexus Schedules Second Quarter 2023 Conference Call

RSS
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • ...13
Next
© 2023 Medexus Pharmaceuticals, Inc.
All Rights Reserved.
Facebook Facebook
Privacy Policy Disclaimer Sitemap

Market Data copyright © 2023 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.